Opicapone versus placebo in the treatment of Parkinson’s disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial

K. Ray Chaudhuri, Per Odin, Joaquim J. Ferreira, Angelo Antonini, Olivier Rascol, Mónica M. Kurtis, Alexander Storch, Kirsty Bannister, Patrício Soares-da-Silva, Raquel Costa, Diogo Magalhães, José Francisco Rocha

Open source

DOI: 10.1186/s12883-022-02602-8
Published: 2022-03-12
Container: BMC Neurology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12883-022-02602-8,
  title = {Opicapone versus placebo in the treatment of Parkinson’s disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial},
  author = {K. Ray Chaudhuri and Per Odin and Joaquim J. Ferreira and Angelo Antonini and Olivier Rascol and Mónica M. Kurtis and Alexander Storch and Kirsty Bannister and Patrício Soares-da-Silva and Raquel Costa and Diogo Magalhães and José Francisco Rocha},
  year = {2022},
  journal = {BMC Neurology},
  doi = {10.1186/s12883-022-02602-8},
  url = {https://doi.org/10.1186/s12883-022-02602-8}
}

RIS

TY  - JOUR
TI  - Opicapone versus placebo in the treatment of Parkinson’s disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial
AU  - K. Ray Chaudhuri
AU  - Per Odin
AU  - Joaquim J. Ferreira
AU  - Angelo Antonini
AU  - Olivier Rascol
AU  - Mónica M. Kurtis
AU  - Alexander Storch
AU  - Kirsty Bannister
AU  - Patrício Soares-da-Silva
AU  - Raquel Costa
AU  - Diogo Magalhães
AU  - José Francisco Rocha
PY  - 2022
JO  - BMC Neurology
DO  - 10.1186/s12883-022-02602-8
UR  - https://doi.org/10.1186/s12883-022-02602-8
ER  -

APA

Chaudhuri, K. R., Odin, P., Ferreira, J. J., Antonini, A., Rascol, O., Kurtis, M. M., Storch, A., Bannister, K., Soares-da-Silva, P., Costa, R., Magalhães, D., & Rocha, J. F. (2022). Opicapone versus placebo in the treatment of Parkinson’s disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial. BMC Neurology. https://doi.org/10.1186/s12883-022-02602-8

Source records

crossref · retrieved 2026-09-26T18:54:06.520Z